Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamatergic Modulation of Motivation Enhancement in Cocaine Use Disorder
NCT02373124Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Dec 2014
- Primary completion
- Oct 2016
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in cocaine use disorder (CUD), sponsored by New York State Psychiatric Institute. Primary endpoint: Cocaine Use at 5 weeks. Started Dec 2014; status: completed.
02
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT02373124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02373124.